Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Numit versus placebo for pain during pediatric pulsed dye or Nd:YAG laser procedures
ACTRN12623000494639Phase 2Completed
- Sponsor
- Queensland Children's Hospital
- Start
- Oct 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in severe cutaneous adverse reactions (SCAR) and vascular abnormality comparing Numit 5% topical anaesthetic with Placebo cream (2 arms). Primary endpoint: Feasibility composite outcome. Started Oct 2023; status: completed.
02
Drugs
lidocaine + prilocaine
03
Conditions
severe cutaneous adverse reactions (SCAR)vascular abnormality
Beyond the preview
Go deeper on ACTRN12623000494639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000494639.